Financials Kewaunee Scientific Corporation

Equities

KEQU

US4928541048

Business Support Supplies

Market Closed - Nasdaq 04:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
43.15 USD -0.25% Intraday chart for Kewaunee Scientific Corporation -7.32% +48.43%

Valuation

Fiscal Period: Aprile 2019 2020 2021 2022 2023 2024
Capitalization 1 62.16 28.14 33.15 39.78 45.99 102.6
Enterprise Value (EV) 1 62.43 37.69 44.1 74.14 79.61 118.5
P/E ratio 41.1 x -6 x -9.02 x -6.48 x 65 x 5.6 x
Yield 3.27% 3.71% - - - -
Capitalization / Revenue 0.42 x 0.19 x 0.22 x 0.24 x 0.21 x 0.5 x
EV / Revenue 0.43 x 0.26 x 0.3 x 0.44 x 0.36 x 0.58 x
EV / EBITDA 12.8 x 72.1 x 181 x 85.3 x 9.75 x 6.88 x
EV / FCF -79.2 x 14.2 x -34.2 x -3.87 x 18.9 x 8.05 x
FCF Yield -1.26% 7.03% -2.92% -25.9% 5.29% 12.4%
Price to Book 1.32 x 0.73 x 0.8 x 1.11 x 1.23 x 1.85 x
Nbr of stocks (in thousands) 2,747 2,751 2,763 2,790 2,830 2,875
Reference price 2 22.63 10.23 12.00 14.26 16.25 35.70
Announcement Date 7/11/19 7/27/20 7/15/21 7/1/22 6/30/23 6/28/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2019 2020 2021 2022 2023 2024
Net sales 1 146.6 147.5 147.5 168.9 219.5 203.8
EBITDA 1 4.89 0.523 0.243 0.869 8.167 17.23
EBIT 1 2.319 -2.131 -2.444 -1.9 5.3 14.1
Operating Margin 1.58% -1.44% -1.66% -1.13% 2.41% 6.92%
Earnings before Tax (EBT) 1 2.134 -2.866 -2.617 -2.485 4.498 13.12
Net income 1 1.529 -4.687 -3.672 -6.126 0.738 18.75
Net margin 1.04% -3.18% -2.49% -3.63% 0.34% 9.2%
EPS 2 0.5500 -1.704 -1.330 -2.200 0.2500 6.380
Free Cash Flow 1 -0.788 2.648 -1.288 -19.17 4.211 14.72
FCF margin -0.54% 1.79% -0.87% -11.35% 1.92% 7.23%
FCF Conversion (EBITDA) - 506.31% - - 51.56% 85.46%
FCF Conversion (Net income) - - - - 570.56% 78.52%
Dividend per Share 2 0.7400 0.3800 - - - -
Announcement Date 7/11/19 7/27/20 7/15/21 7/1/22 6/30/23 6/28/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: Aprile 2019 2020 2021 2022 2023 2024
Net Debt 1 0.28 9.55 10.9 34.4 33.6 15.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.0571 x 18.26 x 45.03 x 39.54 x 4.116 x 0.921 x
Free Cash Flow 1 -0.79 2.65 -1.29 -19.2 4.21 14.7
ROE (net income / shareholders' equity) 3.52% -10.7% -9% -15.5% 3.64% 40.2%
ROA (Net income/ Total Assets) 1.68% -1.56% -1.76% -1.14% 2.79% 6.95%
Assets 1 90.89 301.2 208.3 536.9 26.48 269.8
Book Value Per Share 2 17.10 14.00 14.90 12.80 13.20 19.30
Cash Flow per Share 2 3.880 1.590 1.880 1.590 2.850 8.200
Capex 1 4.21 2.47 2.4 1.91 4.15 4.37
Capex / Sales 2.87% 1.67% 1.63% 1.13% 1.89% 2.15%
Announcement Date 7/11/19 7/27/20 7/15/21 7/1/22 6/30/23 6/28/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. KEQU Stock
  4. Financials Kewaunee Scientific Corporation